155 related articles for article (PubMed ID: 38762042)
1. Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease.
Nordanstig J; Mani K
Eur J Vasc Endovasc Surg; 2024 May; ():. PubMed ID: 38762042
[No Abstract] [Full Text] [Related]
2. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778
[TBL] [Abstract][Full Text] [Related]
3. Peripheral drug-eluting technology.
Franzone A; Stabile E; Trimarco B; Esposito G
Cardiol Clin; 2015 Feb; 33(1):151-62. PubMed ID: 25439337
[TBL] [Abstract][Full Text] [Related]
4. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease.
Altit R; Gray WA
Curr Cardiol Rep; 2017 Oct; 19(11):117. PubMed ID: 29027096
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
[TBL] [Abstract][Full Text] [Related]
6. [Absorbable coronary stents. New promising technology].
Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
[TBL] [Abstract][Full Text] [Related]
7. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.
Varcoe RL; Schouten O; Thomas SD; Lennox AF
JACC Cardiovasc Interv; 2016 Aug; 9(16):1721-8. PubMed ID: 27539693
[TBL] [Abstract][Full Text] [Related]
8. Infrapopliteal drug-eluting stents for chronic limb ischemia.
Grant AG; White CJ; Collins TJ; Jenkins JS; Reilly JP; Ramee SR
Catheter Cardiovasc Interv; 2008 Jan; 71(1):108-11. PubMed ID: 18098211
[TBL] [Abstract][Full Text] [Related]
9. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
Brizzi V; Caradu C; Berard X; Sassoust G; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2018 Oct; 59(5):707-715. PubMed ID: 27879958
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the use of drug eluting stents in below-the-knee lesions.
Trombert D; Caradu C; Brizzi V; Bérard X; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2015 Feb; 56(1):67-71. PubMed ID: 25428562
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting stents in the management of peripheral arterial disease.
Bosiers M; Cagiannos C; Deloose K; Verbist J; Peeters P
Vasc Health Risk Manag; 2008; 4(3):553-9. PubMed ID: 18827906
[TBL] [Abstract][Full Text] [Related]
12. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents in the below-knee circulation for patients with critical limb ischemia: when and where.
Ward TJ; Lookstein RA
Tech Vasc Interv Radiol; 2014 Sep; 17(3):177-82. PubMed ID: 25241318
[TBL] [Abstract][Full Text] [Related]
14. Drug-coated balloons for coronary and peripheral interventional procedures.
Wöhrle J
Curr Cardiol Rep; 2012 Oct; 14(5):635-41. PubMed ID: 22825918
[TBL] [Abstract][Full Text] [Related]
15. Infrapopliteal stents: overview and unresolved issues.
Karnabatidis D; Katsanos K; Siablis D
J Endovasc Ther; 2009 Feb; 16 Suppl 1():I153-62. PubMed ID: 19317574
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of sirolimus-eluting stents for treatment of below-the-knee arterial disease.
Fong KY; Xin L; Ng J; Loh SEK; Ng JJ; Choong AMTL
J Vasc Surg; 2023 Apr; 77(4):1264-1273.e3. PubMed ID: 36183989
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y; Torsello G; Zeller T; Esposito G; Vermassen F; Hausegger KA; Tepe G; Thieme M; Gschwandtner M; Kahlberg A; Schindewolf M; Sapoval M; Diaz-Cartelle J; Stavroulakis K;
Circulation; 2022 Nov; 146(21):1564-1576. PubMed ID: 36254728
[TBL] [Abstract][Full Text] [Related]
18. Drug eluting stents in the treatment of below the knee arterial occlusive disease.
Varcoe RL
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):313-25. PubMed ID: 23640354
[TBL] [Abstract][Full Text] [Related]
19. Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option?
Spiliopoulos S; Kitrou PM; Brountzos EN
World J Cardiol; 2018 Nov; 10(11):196-200. PubMed ID: 30510636
[TBL] [Abstract][Full Text] [Related]
20. Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial.
Gouëffic Y; Kaladji A; Guyomarch B; Montagne C; Fairier D; Gestin S; Riche VP; Vent PA; Chaillou P; Costargent A; Patra P
Trials; 2014 Oct; 15():423. PubMed ID: 25359394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
